Buxton Resources Ltd (ASX:BUX) Reports High-Grade Graphite Intersections
Buxton Resources Ltd reports significant high-grade graphite results at Graphite Bull, anticipating further resource growth.
Category: Healthcare
LTR Pharma Limited (ASX:LTP) Launches Online Men’s Health Platform
LTR Pharma launches its online telehealth platform for men’s health, enabling access to SPONTAN treatment ahead of schedule.
BCAL Diagnostics Limited (ASX:BDX) Receives NATA Accreditation
BCAL Diagnostics Limited (ASX: BDX) receives NATA accreditation, advancing its BREASTEST® commercialisation efforts.
Capitol Health Limited (ASX:CAJ) Scheme Becomes Effective
Capitol Health announces the effective implementation of its acquisition by Integral Diagnostics, leading to trading suspension on the ASX.
LiveHire Ltd (ASX: LVH) Announces Takeover Offer Recommendation
LiveHire Ltd (ASX: LVH) recommended shareholders accept Humanforce’s unconditional takeover offer at $0.045 per share.
Titomic Limited (ASX:TTT) Co-Develops Cold Spray Standard
Titomic Limited announces the successful co-development and acceptance of a new cold spray standard with SAE International, enhancing its market position.
HealthCo Healthcare & Wellness REIT (ASX: HCW) Announces Valuations and Distribution
HealthCo Healthcare & Wellness REIT (HCW) announces property valuations increase and declares distribution for December 2024.
PainChek Limited (ASX:PCK) Expands Implementation and Market Reach
PainChek Limited (ASX:PCK) reports growth in implemented licenses and new government partnerships enhancing market opportunities.
Syntara Limited (ASX:SNT) Announces Positive Phase 2 Trial Results
Syntara Limited reports positive interim data from its Phase 2 trial of SNT-5505, indicating potential as a breakthrough treatment for myelofibrosis.
Syntara Limited (ASX:SNT) Presents Interim Data from SNT-5505 Trial
Positive interim data from Syntara Limited’s SNT-5505 trial in myelofibrosis indicates significant clinical potential.